For persons diagnosed with HIV aged 50 years and older, progress on quality of life goals is limited, according to study findings.

Implementation of opt-out ED syphilis screening leads to a dramatic increase in screening and diagnosis, especially among pregnant individuals.

Researchers determined persistence of iron deficiency was common in patients with an iron deficiency diagnosis.

Twice-yearly lenacapavir was found to be superior to daily emtricitabine 200mg and tenofovir disoproxil fumarate 300mg.

In pediatric sepsis, illness severity, immunocompromised status, invasive procedures, and infection site are all linked to secondary and/or prolonged infection. Lymphopenia is an independent risk ...

Self-compassion among adolescents and young adults with inflammatory bowel diseases may lead to better psychosocial and physical health.

A single dose of chikungunya vaccine is safe, effective, provides protection up to 2 years, and does not result in any long-term serious AEs related to vaccination.

Statistics from 2023 on United States obesity rates reveal that in every US state, 1 in every 5 people now has obesity.

A study investigating GSK’s investigational herpes simplex virus (HSV) vaccine candidate failed to meet its primary efficacy endpoint.

Language barrier may reduce a patient’s ability to convey cardiac vs noncardiac chest pain, thereby adversely impacting his or her health care experience.

It could be a real breakthrough for people at risk for HIV infection: A shot given every 6 months that reduces their risk by a whopping 96%.

The FDA has approved Tremfya® (guselkumab) for the treatment of adult patients with moderately to severely active ulcerative colitis (UC).